Comparison of bleeding and thrombotic outcomes in veno-venous extracorporeal membrane oxygenation: Heparin versus bivalirudin.
Thomas KartikaRick MathewsGina MignecoTaylor BundyAndy J KaempfMichael PfefferThomas G DeLougheryKerry MooreRachel BeardshearHeath J OetkenJonathan CaseMonica T HindsOwen J T McCartyJoseph J ShatzelDavid ZoniesBishoy L ZakharyPublished in: European journal of haematology (2023)
In this real-world analysis of bivalirudin versus heparin, bivalirudin is a viable option for V-V ECMO and associated with lower risk of thrombotic complications and fewer transfusion requirements.